| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Mark T. Iwicki | Director | Oct 23, 2025 | Sale | $0.81 | 154,894 | 125,464 | 103,540 | Oct 24, 2025, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mark T. Iwicki | Director | Jun 24, 2025 | Sale | $4.01 | 13,227 | 53,040 | 258,433 | Jun 26, 2025, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mark T. Iwicki | Director | Jun 03, 2025 | Sale | $3.74 | 10,866 | 40,639 | 269,210 | Jun 05, 2025, 09:44 PM | |
| KALA | KALA BIO, Inc. | Mark T. Iwicki | Director | Jun 03, 2025 | Sale | $3.74 | 10,866 | 40,639 | 269,210 | Jun 04, 2025, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Jan 06, 2025 | Sale | $7.63 | 5,779 | 44,094 | 280,076 | Jan 07, 2025, 08:12 PM | |
| KALA | KALA BIO, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Jun 26, 2024 | Sale | $4.75 | 15,168 | 72,048 | 263,755 | Jun 27, 2024, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | May 31, 2024 | Sale | $6.09 | 7,392 | 45,017 | 278,923 | Jun 03, 2024, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Jan 04, 2024 | Sale | $6.73 | 4,539 | 30,547 | 286,315 | Jan 05, 2024, 04:04 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Jan 04, 2023 | Sale | $28.54 | 198 | 5,651 | 45,966 | Jan 06, 2023, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Oct 26, 2022 | Sale | $6.52 | 561 | 3,658 | 4,464 | Oct 28, 2022, 04:15 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Jun 27, 2022 | Sale | $0.37 | 7,975 | 2,951 | 251,183 | Jun 29, 2022, 08:09 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Jan 04, 2022 | Sale | $1.30 | 9,518 | 12,373 | 259,158 | Jan 05, 2022, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Oct 26, 2021 | Sale | $1.80 | 27,598 | 49,676 | 268,676 | Oct 28, 2021, 08:01 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mark T. Iwicki | CHIEF EXECUTIVE OFFICER | Jun 28, 2021 | Sale | $5.77 | 7,586 | 43,771 | 296,274 | Jun 29, 2021, 05:25 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More